- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
U.S. House Oversight and Government Reform Subcommittee Holds Hearing on Drug Shortages
Congressional hearings on drug shortages continue due in part to continued efforts of the American Society of Clinical Oncology (ASCO) and the medical community to raise awareness and seek solutions to this crisis. On Nov. 30, the U.S. House of Representatives Oversight and Government Reform Subcommittee on Health Care, District of Columbia, Census and the National Archives convened a hearing on the issue.
Michelle Hudspeth, MD, director of the Pediatric Hematology/Oncology Division at the Medical University of South Carolina, testified that “the current situation is nothing short of a massive national emergency” and that the shortages were severely impacting cancer care.
Dr. Hudspeth also discussed why she felt the reimbursement model created through the Medicare Modernization Act of 2003 has helped lead to the shortages.
Read the full report at: http://tinyurl.com/7xta8rv
Source: Oncology Business Review; ASCO
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
